CADL vs PARA · $592.0M cap vs rev $5.0M
Candel Therapeutics Inc (CADL) versus PARA (PARA) — a side-by-side from cached financials, not a winner call.
Candel Therapeutics Inc (CADL) is a biotechnology company listed on NASDAQ.
PARA (PARA) common stock.
CADL does not have a complete income-statement cache yet.
Latest reported PARA revenue for 2026-06-30 was $5.0M. Net income was -$13.4M. Revenue was up 84.3% from 2026-03-31 to 2026-06-30. PARA currently screens at market cap $0.
CADL currently screens at market cap $592.0M. PARA currently screens at market cap $0.
Not investment advice. Open the CADL and PARA stock pages for the full models.
Not investment advice.